Clot-activated polymer composition of PRP and chitosan.
Patents granted in the United States of America, Europe (Germany, Spain, France, United Kingdom and Italy), and Canada.
Freeze dried chitosan and lyoprotectant for use with PRP, blood and combinations to form an injectable solution.
Patents granted in United States of America, Japan, Europe (Germany, Spain, France, United Kingdom and Italy), Canada and Australia.
Lyophilized scaffold comprising at least one polysaccharide, to have a variety of beneficial effects for tissue repair.
Patents granted in Japan and Australia. Currently undergoing examination in United States of America, Europe and Canada.